BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lv DW, Zhang K, Li R. Interferon regulatory factor 8 regulates caspase-1 expression to facilitate Epstein-Barr virus reactivation in response to B cell receptor stimulation and chemical induction. PLoS Pathog 2018;14:e1006868. [PMID: 29357389 DOI: 10.1371/journal.ppat.1006868] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang X, He Y, Zhang P, Budamagunta V, Lv D, Thummuri D, Yang Y, Pei J, Yuan Y, Zhou D, Zheng G. Discovery of IAP-recruiting BCL-XL PROTACs as potent degraders across multiple cancer cell lines. Eur J Med Chem 2020;199:112397. [PMID: 32388279 DOI: 10.1016/j.ejmech.2020.112397] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
2 Li CW, Jheng BR, Chen BS. Investigating genetic-and-epigenetic networks, and the cellular mechanisms occurring in Epstein-Barr virus-infected human B lymphocytes via big data mining and genome-wide two-sided NGS data identification. PLoS One 2018;13:e0202537. [PMID: 30133498 DOI: 10.1371/journal.pone.0202537] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
3 Lin Z, Li Y, Gong G, Xia Y, Wang C, Chen Y, Hua L, Zhong J, Tang Y, Liu X, Zhu B. Restriction of H1N1 influenza virus infection by selenium nanoparticles loaded with ribavirin via resisting caspase-3 apoptotic pathway. Int J Nanomedicine 2018;13:5787-97. [PMID: 30310281 DOI: 10.2147/IJN.S177658] [Cited by in Crossref: 31] [Cited by in F6Publishing: 15] [Article Influence: 7.8] [Reference Citation Analysis]
4 Wang H, Yang L, Qu H, Feng H, Wu S, Bao W. Global Mapping of H3K4 Trimethylation (H3K4me3) and Transcriptome Analysis Reveal Genes Involved in the Response to Epidemic Diarrhea Virus Infections in Pigs. Animals (Basel) 2019;9:E523. [PMID: 31382472 DOI: 10.3390/ani9080523] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
5 Van Sciver N, Ohashi M, Nawandar DM, Pauly NP, Lee D, Makielski KR, Bristol JA, Tsao SW, Lambert PF, Johannsen EC, Kenney SC. ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cells. PLoS Pathog 2021;17:e1010045. [PMID: 34748616 DOI: 10.1371/journal.ppat.1010045] [Reference Citation Analysis]
6 Van Sciver N, Ohashi M, Pauly NP, Bristol JA, Nelson SE, Johannsen EC, Kenney SC. Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells. PLoS Pathog 2021;17:e1009783. [PMID: 34339458 DOI: 10.1371/journal.ppat.1009783] [Reference Citation Analysis]
7 Alomari M. TRIM21 - A potential novel therapeutic target in cancer. Pharmacol Res 2021;165:105443. [PMID: 33508433 DOI: 10.1016/j.phrs.2021.105443] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Forbes LR, Eckstein OS, Gulati N, Peckham-Gregory EC, Ozuah NW, Lubega J, El-Mallawany NK, Agrusa J, Poli MC, Vogel TP, Chaimowitz NS, Rider NL, Mace EM, Orange JS, Caldwell JW, Aldave-Becerra JC, Jolles S, Saettini F, Chong HJ, Stray-Pedersen A, Heslop HE, Kamdar KY, Rouce RH, Muzny DM, Jhangiani SN, Gibbs RA, Coban-Akdemir ZH, Lupski JR, McClain KL, Allen CE, Chinn IK. Genetic errors of immunity distinguish pediatric non-malignant lymphoproliferative disorders. J Allergy Clin Immunol 2021:S0091-6749(21)01135-0. [PMID: 34329649 DOI: 10.1016/j.jaci.2021.07.015] [Reference Citation Analysis]
9 Zhang K, Lv DW, Li R. Conserved Herpesvirus Protein Kinases Target SAMHD1 to Facilitate Virus Replication. Cell Rep 2019;28:449-459.e5. [PMID: 31291580 DOI: 10.1016/j.celrep.2019.04.020] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 16.0] [Reference Citation Analysis]
10 Zhang K, Lv DW, Li R. Protein inhibitor of activated STAT1 (PIAS1) inhibits IRF8 activation of Epstein-Barr virus lytic gene expression. Virology 2020;540:75-87. [PMID: 31743858 DOI: 10.1016/j.virol.2019.11.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
11 Heward E, Rocke J, Kumar N, Izzat S. Recurrent tonsillitis and parental perceptions of tonsillectomy during the COVID-19 pandemic. Int J Pediatr Otorhinolaryngol 2020;139:110463. [PMID: 33120105 DOI: 10.1016/j.ijporl.2020.110463] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Tabtieng T, Gaglia MM. Emerging Proviral Roles of Caspases during Lytic Replication of Gammaherpesviruses. J Virol 2018;92:e01011-17. [PMID: 30021896 DOI: 10.1128/JVI.01011-17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Saiada F, Zhang K, Li R. PIAS1 potentiates the anti-EBV activity of SAMHD1 through SUMOylation. Cell Biosci 2021;11:127. [PMID: 34238351 DOI: 10.1186/s13578-021-00636-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Zheng Z, Fu X, Ling X, Sun H, Li Y, Ma Z, Wei B, Zheng H, Xiao S. Host Cells Actively Resist Porcine Reproductive and Respiratory Syndrome Virus Infection via the IRF8-MicroRNA-10a-SRP14 Regulatory Pathway. J Virol 2022;:e0000322. [PMID: 35293774 DOI: 10.1128/jvi.00003-22] [Reference Citation Analysis]
15 Zhang K, Zhang Y, Maharjan Y, Sugiokto FG, Wan J, Li R. Caspases Switch off the m6A RNA Modification Pathway to Foster the Replication of a Ubiquitous Human Tumor Virus. mBio 2021;12:e0170621. [PMID: 34425696 DOI: 10.1128/mBio.01706-21] [Reference Citation Analysis]
16 Long X, Yang J, Zhang X, Yang Z, Li Y, Wang F, Li X, Kuang E. BRLF1 suppresses RNA Pol III-mediated RIG-I inflammasome activation in the early EBV lytic lifecycle. EMBO Rep 2021;22:e50714. [PMID: 33225563 DOI: 10.15252/embr.202050714] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Nayak V, Singh KR, Singh AK, Singh RP. Potentialities of selenium nanoparticles in biomedical science. New J Chem 2021;45:2849-78. [DOI: 10.1039/d0nj05884j] [Cited by in Crossref: 16] [Article Influence: 16.0] [Reference Citation Analysis]
18 Chen S, Fang T, Xiao S, Lin F, Cheng X, Wang S, Zhu X, Chen X, Zheng M, Munir M, Huang M, Yu F, Chen S. Duckling short beak and dwarfism syndrome virus infection activates host innate immune response involving both DNA and RNA sensors. Microb Pathog 2020;138:103816. [PMID: 31655218 DOI: 10.1016/j.micpath.2019.103816] [Reference Citation Analysis]
19 Cornut M, Bourdonnay E, Henry T. Transcriptional Regulation of Inflammasomes. Int J Mol Sci 2020;21:E8087. [PMID: 33138274 DOI: 10.3390/ijms21218087] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
20 Skerniškytė J, Karazijaitė E, Lučiūnaitė A, Sužiedėlienė E. OmpA Protein-Deficient Acinetobacter baumannii Outer Membrane Vesicles Trigger Reduced Inflammatory Response. Pathogens 2021;10:407. [PMID: 33807410 DOI: 10.3390/pathogens10040407] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Sausen DG, Bhutta MS, Gallo ES, Dahari H, Borenstein R. Stress-Induced Epstein-Barr Virus Reactivation. Biomolecules 2021;11:1380. [PMID: 34572593 DOI: 10.3390/biom11091380] [Reference Citation Analysis]
22 Lv D, Pal P, Liu X, Jia Y, Thummuri D, Zhang P, Hu W, Pei J, Zhang Q, Zhou S, Khan S, Zhang X, Hua N, Yang Q, Arango S, Zhang W, Nayak D, Olsen SK, Weintraub ST, Hromas R, Konopleva M, Yuan Y, Zheng G, Zhou D. Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity. Nat Commun 2021;12:6896. [PMID: 34824248 DOI: 10.1038/s41467-021-27210-x] [Reference Citation Analysis]
23 Khan S, Zhang X, Lv D, Zhang Q, He Y, Zhang P, Liu X, Thummuri D, Yuan Y, Wiegand JS, Pei J, Zhang W, Sharma A, McCurdy CR, Kuruvilla VM, Baran N, Ferrando AA, Kim YM, Rogojina A, Houghton PJ, Huang G, Hromas R, Konopleva M, Zheng G, Zhou D. A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity. Nat Med 2019;25:1938-47. [PMID: 31792461 DOI: 10.1038/s41591-019-0668-z] [Cited by in Crossref: 99] [Cited by in F6Publishing: 92] [Article Influence: 33.0] [Reference Citation Analysis]
24 Gao L, Han H, Wang H, Cao L, Feng WH. IL-10 knockdown with siRNA enhances the efficacy of Doxorubicin chemotherapy in EBV-positive tumors by inducing lytic cycle via PI3K/p38 MAPK/NF-kB pathway. Cancer Lett 2019;462:12-22. [PMID: 31352079 DOI: 10.1016/j.canlet.2019.07.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
25 Murata T, Sugimoto A, Inagaki T, Yanagi Y, Watanabe T, Sato Y, Kimura H. Molecular Basis of Epstein-Barr Virus Latency Establishment and Lytic Reactivation. Viruses 2021;13:2344. [PMID: 34960613 DOI: 10.3390/v13122344] [Reference Citation Analysis]
26 Burton EM, Goldbach-Mansky R, Bhaduri-McIntosh S. A promiscuous inflammasome sparks replication of a common tumor virus. Proc Natl Acad Sci U S A 2020;117:1722-30. [PMID: 31919284 DOI: 10.1073/pnas.1919133117] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
27 Jangra S, Yuen KS, Botelho MG, Jin DY. Epstein-Barr Virus and Innate Immunity: Friends or Foes? Microorganisms 2019;7:E183. [PMID: 31238570 DOI: 10.3390/microorganisms7060183] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
28 Guo R, Jiang C, Zhang Y, Govande A, Trudeau SJ, Chen F, Fry CJ, Puri R, Wolinsky E, Schineller M, Frost TC, Gebre M, Zhao B, Giulino-Roth L, Doench JG, Teng M, Gewurz BE. MYC Controls the Epstein-Barr Virus Lytic Switch. Mol Cell 2020;78:653-669.e8. [PMID: 32315601 DOI: 10.1016/j.molcel.2020.03.025] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
29 He Y, Zhang X, Chang J, Kim HN, Zhang P, Wang Y, Khan S, Liu X, Zhang X, Lv D, Song L, Li W, Thummuri D, Yuan Y, Wiegand JS, Ortiz YT, Budamagunta V, Elisseeff JH, Campisi J, Almeida M, Zheng G, Zhou D. Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity. Nat Commun 2020;11:1996. [PMID: 32332723 DOI: 10.1038/s41467-020-15838-0] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 22.0] [Reference Citation Analysis]
30 Liu L, Ma F, Hao Y, Yi Z, Yu X, Xu B, Wei C, Hu J. Integrative Informatics Analysis of Transcriptome and Identification of Interacted Genes in the Glomeruli and Tubules in CKD. Front Med (Lausanne) 2020;7:615306. [PMID: 33644086 DOI: 10.3389/fmed.2020.615306] [Reference Citation Analysis]
31 Davis DA, Shrestha P, Aisabor AI, Stream A, Galli V, Pise-Masison CA, Tagawa T, Ziegelbauer JM, Franchini G, Yarchoan R. Pomalidomide increases immune surface marker expression and immune recognition of oncovirus-infected cells. Oncoimmunology 2019;8:e1546544. [PMID: 30713808 DOI: 10.1080/2162402X.2018.1546544] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]